To further understand the role of SphK1 in mesothelioma cell proliferation, we next treated the cells with SphK inhibitor and determined the effect on phosphorylation of cyclin dependent kinase 2 (CDK2), which is essential for eukaryotic cell cycle G1/S phase transition. This evidence concerns the gene CDK2 and mesothelioma.